IMCOOI
VRTX icon

Investment Management Corp of Ontario (IMCO)’s Vertex Pharmaceuticals VRTX Stock Holding History

Investment Management Corp of Ontario (IMCO)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.05M Sell
16,215
-3,347
-17% -$1.48M 0.1% 189
2026
Q1 		$8.74M Sell
19,562
-2,738
-12% -$1.28M 0.11% 179
2025
Q4 		$10.1M Buy
22,300
+7,065
+46% +$3.05M 0.13% 140
2025
Q3 		$5.97M Buy
15,235
+3,560
+30% +$1.49M 0.09% 169
2025
Q2 		$5.2M Sell
11,675
-3,092
-21% -$1.42M 0.08% 172
2025
Q1 		$7.16M Sell
14,767
-2,530
-15% -$1.18M 0.15% 113
2024
Q4 		$6.97M Sell
17,297
-6,288
-27% -$2.91M 0.23% 61
2024
Q3 		$11M Buy
23,585
+2,600
+12% +$1.25M 0.24% 67
2024
Q2 		$9.84M Buy
20,985
+1,700
+9% +$738K 0.27% 60
2024
Q1 		$8.06M Sell
19,285
-24,775
-56% -$10.5M 0.24% 65
2023
Q4 		$17.9M Buy
44,060
+6,563
+18% +$2.42M 0.44% 43
2023
Q3 		$13M Buy
37,497
+10,889
+41% +$3.81M 0.51% 33
2023
Q2 		$9.36M Sell
26,608
-3,401
-11% -$1.15M 0.4% 32
2023
Q1 		$9.45M Buy
30,009
+1,912
+7% +$573K 0.39% 30
2022
Q4 		$8.11M Buy
+28,097
New +$8.56M 0.4% 31

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Investment Management Corp of Ontario (IMCO)'s VRTX Position: Q2 2026 in Review

Investment Management Corp of Ontario (IMCO) reduced its Vertex Pharmaceuticals (VRTX) stake by 17% in Q2 2026, selling an estimated $1.48M and leaving 16,215 shares worth $8.05M. The position accounts for 0.1% of the portfolio, ranked #189.

Investment Management Corp of Ontario (IMCO) first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $17.9M in Q4 2023. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Investment Management Corp of Ontario (IMCO) held 16,215 shares of Vertex Pharmaceuticals worth $8.05M as of Q2 2026.
  • Investment Management Corp of Ontario (IMCO) sold 3,347 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.48M.
  • Vertex Pharmaceuticals made up 0.1% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #189 holding.
  • Investment Management Corp of Ontario (IMCO) first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Investment Management Corp of Ontario (IMCO)'s Vertex Pharmaceuticals position peaked at $17.9M in Q4 2023.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.